Resmed (RSMDF) Other Accumulated Expenses (2010 - 2021)

Resmed (RSMDF) has reported Other Accumulated Expenses for 12 consecutive years, with $12.3 million the latest figure, recorded in Q2 2021.

• For the quarter ending Q2 2021, Other Accumulated Expenses fell 1.77% year-over-year to $12.3 million; the trailing twelve-month figure through Jun 2021 stood at $12.3 million (down 1.77% YoY), and the FY2021 full-year result was $12.3 million, down 1.77% from the prior year.
• Other Accumulated Expenses declined to $12.3 million in Q2 2021 per RSMDF's latest filing, from $12.5 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $12.5 million in Q2 2020 and bottomed at $10.9 million in Q2 2017.
• Historically, Other Accumulated Expenses has averaged $11.6 million across 5 years, with a median of $11.4 million in 2019.
• The sharpest annual moves came in 2017 and 2020: Other Accumulated Expenses fell 13.98% in 2017, then grew 9.64% in 2020.
• Over 5 years, Other Accumulated Expenses stood at $10.9 million in 2017, then advanced by 0.93% to $11.0 million in 2018, then gained by 3.6% to $11.4 million in 2019, then advanced by 9.64% to $12.5 million in 2020, then declined by 1.77% to $12.3 million in 2021.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $12.3 million, $12.5 million, and $11.4 million for Q2 2021, Q2 2020, and Q2 2019 respectively.